Bank of America just raised its EUR/USD forecast
In a recent transaction, Selig Zises, a director at Esquire Financial Holdings, Inc. (NASDAQ:ESQ), sold a substantial portion of his holdings in the company. According to a form filed with the Securities and Exchange Commission, Zises sold shares totaling approximately $1.55 million. The sales occurred on February 28, 2025, with the transaction prices ranging from $76.70 to $78.3205 per share. The stock, which has delivered an impressive 56% return over the past year and is currently trading at $74.68, appears undervalued according to InvestingPro analysis.
Following these transactions, Zises holds 37,001 shares directly through a profit-sharing plan. Additionally, he maintains indirect ownership of shares through various trusts and partnerships. Esquire Financial Holdings, based in Jericho, New York, operates in the commercial banking sector. With a market capitalization of $587 million and a P/E ratio of 13.8, the company maintains a "GREAT" financial health score according to InvestingPro, which offers 8 additional key insights about the company’s performance and outlook.
In other recent news, Esquire Financial Holdings has been the subject of notable analyst activity. Keefe, Bruyette & Woods analyst Tim Switzer raised the company’s stock price target to $85, maintaining a Market Perform rating. Switzer highlighted Esquire’s strong operational performance, with a 31% increase in loans and a 28% rise in deposits last quarter, alongside improved noninterest income. The company’s strategic shift from New York commercial real estate to its litigation banking practice is expected to enhance risk-adjusted returns. Meanwhile, Raymond (NSE:RYMD) James downgraded Esquire Financial from "Strong Buy" to "Market Perform" due to concerns about its current valuation after a significant stock price increase. Despite the downgrade, Raymond James acknowledged the company’s robust core deposit generation and loan growth. They noted that the stock’s performance might have been influenced by reduced expectations of Federal Reserve rate cuts and strong growth prospects. However, they expressed caution, citing the stock’s valuation at 14.4 times their 2026 EPS estimates compared to peers at 10.2 times.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.